Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Porto, Porto | Portugal | 2 months ago
contract to carry out research duties within the project “FibroRevert - Modeling and targeting cell-extracellular matrix communication to revert tissue fibrosis” , GA 101221669, funded by the European
-
Deadline: Applications accepted all year round Details Breast and pancreatic tumours are characterised by excessive deposition of extracellular matrix (ECM) components, resulting in extensive fibrosis
-
how strain-induced tissue electrical polarisation influence cell–matrix interactions during lung fibrosis progression. The postholder will develop bioelectronic in vitro platforms to precisely
-
support a growing basic and translational research program focused on extracellular matrix biology, musculoskeletal fibrosis, and tissue regeneration. Dr. Alex Lambi is a plastic and hand surgeon
-
resources are available to establish a vibrant research program. PACCSM supports active basic and clinical research programs in asthma, COPD, cystic fibrosis, sleep disorders, ILD, and ARDS/ALI, and
-
company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease
-
create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and
-
, including adult, pediatric, and cystic fibrosis patients. Working at a Level 1 Trauma Center means no two days are the same! RTs will care for trauma patients, cardiac arrests and high acuity admissions
-
, pediatric, and cystic fibrosis patients. Working at a Level 1 Trauma Center means no two days are the same! RTs will care for trauma patients, cardiac arrests and high acuity admissions. You will
-
company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas